MEDICILON

contact us krjpencn

뉴스현황

Press Events

현재 위치: > 뉴스현황 > Press Events

  • 07
    22

    2015

    Merck & Co. Extends $100M Agenus Cancer Collaboration

    Agenus said today that Merck & Co. has extended their year-old, approximately $100 million-plus collaboration for the discovery and development of therapeutic antibodies against undisclosed Merck immune checkpoints for cancer.

  • 07
    21

    2015

    Vaccine and Biotherapeutic Linked in New Effort to Combat Cancer

    A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials. One therapy is a vaccine that targets a structure on the outside of cancer cells, while the other is an altered enzyme that breaks apart RNA and causes the cell to commit suicide.

  • 07
    20

    2015

    New Tools Developed to Study Protein Formation

    Scientists generated new antibodies that tag essential chemicals involved in protein formation. In this dividing cell, the new antibody marks discrete areas of a critical chemical reaction that occurs when cells divide.

  • 07
    17

    2015

    Pfizer CTI, Foundation Launch Immunological Disease Collaboration

    Pfizer’s Centers for Therapeutic Innovation (CTI) and the Jeffrey Modell Foundation (JMF) have agreed to collaborate intended to advance research into immunological diseases.

  • 07
    16

    2015

    Global Biosimilars Market Value Could Hit $55 Billion

    The global biosimilars market value is expected to reach $20 billion by the end of 2015 and could hit $55 billion by 2020, with growth primarily driven by a promising pipeline in active development and government efforts to reduce healthcare spending.